Archives
-
FITC Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-08-31
Build sensitive immunofluorescence and flow cytometry assays around reliable mouse IgG detection, from fixed infected cells to tissue sections. This workflow pairs practical optimization with the antiviral assay logic used to investigate Amt-1, Nrf2/HO-1 signaling, and influenza A virus replication.
-
Primidone: A Mechanism-Aware ALS Research Guide
2026-08-30
Primidone, also known as Mysoline, is more than an established antiepileptic drug: it is a context-dependent probe of TRPM3 and RIPK1 biology. This guide connects target pharmacology, ALS biomarker evidence, assay design, dosing, and translational limitations.
-
Inhaled RNA Rebuilds the Lung Cancer Tumor Microenvironment
2026-08-29
This Nature Communications study develops an inhalable lipid nanoparticle that co-delivers anti-DDR1 scFv mRNA and PD-L1 siRNA to remodel the lung cancer microenvironment. By addressing collagen-mediated T-cell exclusion and PD-L1-mediated immunosuppression together, the approach improved immune access, tumor control, and survival in orthotopic and metastatic mouse models.
-
Pcbp1, Mitochondria, and B Cell Immunity
2026-08-28
The reference study identifies Pcbp1 as a posttranscriptional regulator that preserves mitochondrial electron transport and supports antibody production in B cells. Its Pcbp1–Fdxr mechanism connects RNA binding, iron–sulfur cluster biology, protein synthesis, and germinal center function, providing a framework for studying metabolic control of humoral immunity.
-
Novel PRRSV-1 GD2022 in Southern China
2026-08-28
This 2024 study reports the isolation and characterization of GD2022, a PRRSV-1 strain from southern China, combining cell culture, molecular confirmation, whole-genome analysis, and piglet pathogenicity testing. Its findings indicate that GD2022 belongs to PRRSV-1 subtype 1, carries distinctive changes in the GP3–GP5 antigenic region, and causes respiratory disease, making it relevant to surveillance and diagnostic research.
-
HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody
2026-08-27
HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports sensitive fluorescence detection of human primary antibodies across immunofluorescence, Western blotting, flow cytometry, IHC, and ELISA. Its affinity-purified polyclonal design combines broad epitope recognition with Alexa 488 readout, while species specificity and fluorophore handling remain central to assay reliability.
-
CFDA-SE for Cell Proliferation Tracking
2026-08-27
CFDA-SE, also called Carboxyfluorescein diacetate succinimidyl ester, is a cell-permeable fluorescent dye for measuring viable-cell division by flow cytometry. Esterase activation and intracellular amine coupling create a retained signal that is diluted during cell division, while separate surfaceome studies show why proliferation history should not be mistaken for a molecular interaction readout.
-
Hoechst 33342/PI Double Staining Kit: RCC
2026-08-26
The Hoechst 33342/PI Double Staining Kit combines chromatin condensation detection with membrane-permeability analysis for a more informative fluorescent apoptosis assay. This article explains how to apply that two-axis readout to esculin-treated renal cell carcinoma models while avoiding overinterpretation of PI positivity.
-
Ellagic Acid: CK2 Signaling Meets Senolytic Assays
2026-08-26
Ellagic acid is a selective ATP-competitive CK2 inhibitor for mechanistic cancer biology research. This guide develops a distinct assay strategy that connects CK2 perturbation with senescence questions without overstating evidence for senolytic activity.
-
Berberrubine, Vitamin K Cycling, and Thrombosis
2026-08-25
The reference study integrates a mouse thrombosis model, untargeted metabolomics, coagulation testing, and molecular docking to connect berberrubine hydrochloride with regulation of the vitamin K catalytic cycle. Its findings suggest antithrombotic activity without increased bleeding time in the tested model, while also identifying mechanistic hypotheses that require direct biochemical validation.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody for NETs
2026-08-25
Build sensitive rabbit-primary detection into NETs, immunofluorescence, IHC, ICC, and flow cytometry workflows with a Cy3-conjugated secondary antibody. This practical guide connects the PBDE-47/curcumin reference model to assay design, channel selection, signal amplification, and troubleshooting without overstating what the study demonstrated.
-
HyperScribe T7 High Yield RNA Synthesis Kit Workflow
2026-08-24
Build reproducible T7 RNA polymerase transcription workflows for capped, labeled, modified, and unmodified RNA. This practical guide connects high-yield synthesis with PCMT1-focused ovarian cancer metastasis assays, including RNA interference experiments, transcript detection, and mechanistic follow-up.
-
WSP-5: From H2S Deficiency to Translation
2026-08-24
WSP-5, also known as Washington State Probe-5, offers translational researchers a rapid, reaction-based strategy for connecting hydrogen sulfide deficiency with cellular stress phenotypes. This article interprets diabetic cardiomyopathy findings, outlines validation workflows, and positions live-cell H2S imaging within disease-model and drug-discovery strategy.
-
Epacadostat (INCB024360) Assay Guide
2026-08-23
A scenario-based guide to using Epacadostat (INCB024360), IDO1 inhibitor, in viability, proliferation, cytokine, and immuno-oncology workflows. It explains mechanism, solvent controls, dose selection, interpretation, and practical selection of SKU B6036.
-
EZ Cap™ EPO mRNA for Translational Research
2026-08-22
EZ Cap™ EPO mRNA is a Cap 1, pseudouridine-modified human erythropoietin mRNA designed for efficient mammalian protein expression. Its defined formulation supports mRNA for erythropoiesis research, neuroprotection studies, and delivery-platform development, while preclinical spinal cord injury evidence demonstrates the relevance of targeted EPO mRNA translation.